Long-term clinical outcomes of a phase I trial of intravesical docetaxel in the management of non-muscle-invasive bladder cancer refractory to standard intravesical therapy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples